Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
By J. Tuomilehto, J. Lindström, J. Eriksson, T. Valle, H. Hämäläinen, P. Ilanne-Parikka, S. Keinänen-Kiukaanniemi, M. Laakso, A. Louheranta, M. Rastas and 9 more. New England Journal of Medicine, 2001
10,674 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/66da94eb9cbc43af5b73d2b80f86befcc579c8b0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Epidemiology
In Molecular Biology
Citations in the corpus
- Standards of Medical Care in Diabetes—2012 (2011, background): “In the Finnish study (12), middleaged obese subjects with IGT were randomized to receive either brief diet and exercise counseling (control group) or intensive individualized instruction on weight reduction, food intake, and guidance on increasing physical activity (intervention group).”
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults (2013, background): “The remaining 51 trials (72 articles) were rated good or fair quality (22,23,69-138), and included in the evidence base that was used to formulate the ESs and recommendations.”
- The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes (2003, methodology): “This Swedish study provided the basis for the design of the Da Qing study in China [158], the Finnish Diabetes Prevention Study [159] and the DPP carried out in the United States [16].”
- Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. (2002, background): “Recent studies demonstrate that dietary modification and enhanced physical activity may delay or prevent the transition from impaired glucose tolerance to type 2 diabetes mellitus and provide relevant treatment paradigms for patients with the metabolic syndrome.(21-23) While proper management of the”